Explain this page
Arphra AIPlain-English read on Jack Henry & Associates, Inc.’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Quality composite
A+Top tier
A snapshot of the latest fiscal year’s margins, returns on capital, balance-sheet strength and efficiency, computed from the income statement, balance sheet and cash-flow rows. Source income / balance / cash_flow.
Profitability
Gross margin42.7%
Operating margin23.9%
Net margin19.2%
ROE21.4%
ROA15.0%
ROIC21.8%
Liquidity & leverage
Current ratio1.27×
Quick ratio1.27×
Debt / equity0.00×
Net debt / EBITDA-0.13×
Interest coverage54×
Efficiency & per-share
Asset turnover0.78×
Inventory days0
Days sales out.49
FCF / share$8.05
Book value / share$29.17
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Headline | ||||||||
| Market cap | — | — | — | $11.91B | $13.16B | — | — | — |
| Enterprise value | — | — | — | $11.81B | $13.06B | — | — | — |
| Multiples | ||||||||
| P / E | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | 5.33 | 5.50 | — | — | — |
| EV / FCF | — | — | — | 23.16 | 22.20 | — | — | — |
| Yields | ||||||||
| Earnings yield | — | — | — | +3.21% | +3.46% | — | — | — |
| Free cash flow yield | — | — | — | +4.28% | +4.47% | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin | +39.52% | +41.91% | +41.33% | +41.35% | +42.71% | +42.55% | +42.02% | +42.48% |
| Operating margin | +22.68% | +24.43% | +23.14% | +22.09% | +23.94% | +23.14% | +22.92% | +23.29% |
| EBITDA margin | +39.63% | +33.57% | +32.75% | +32.24% | +33.73% | +33.84% | +33.47% | +32.78% |
| EBIT margin | +22.68% | +24.43% | +23.57% | +23.22% | +25.11% | +23.61% | +24.52% | +24.37% |
| Pre-tax margin | +22.62% | +24.31% | +22.84% | +22.48% | +24.67% | +22.92% | +23.54% | +22.80% |
| Net margin | +17.71% | +18.68% | +17.65% | +17.23% | +19.19% | +18.12% | +18.22% | +18.23% |
| Cost structure | ||||||||
| Cost of revenue / sales | +60.48% | +58.09% | +58.67% | +58.65% | +57.29% | +58.76% | +59.00% | +58.24% |
| R&D intensity | +6.20% | +6.25% | +6.87% | +6.69% | +6.85% | +6.74% | +6.76% | +6.69% |
| SG&A intensity | +10.64% | +11.24% | +11.32% | +12.57% | +11.92% | +11.70% | +11.91% | +12.24% |
| Effective tax rate | +21.69% | +23.15% | +22.74% | +23.33% | +22.23% | +22.64% | +22.64% | +23.75% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Returns | ||||||||
| Return on equity (ROE) | +22.54% | +22.56% | +19.90% | +17.92% | +21.39% | +20.32% | +19.96% | +19.58% |
| Return on assets (ROA) | +12.68% | +13.08% | +12.54% | +12.54% | +14.97% | +13.14% | +13.58% | +13.49% |
| Return on capital (ROC) | +26.64% | +25.20% | +24.13% | +22.97% | +26.69% | +25.27% | +24.46% | +24.39% |
| Return on invested capital (ROIC) | +20.81% | +19.27% | +18.40% | +17.92% | +21.39% | +19.79% | +19.45% | +19.09% |
| Asset turnover | +71.60% | +70.04% | +71.05% | +72.78% | +78.03% | +72.50% | +74.54% | +73.98% |
| DuPont · ROE decomposition | ||||||||
| Net margin | +17.71% | +18.68% | +17.65% | +17.23% | +19.19% | +18.12% | +18.22% | +18.23% |
| Asset turnover (× revenue / assets) | +71.60% | +70.04% | +71.05% | +72.78% | +78.03% | +72.50% | +74.54% | +73.98% |
| Equity multiplier (× assets / equity) | +177.73% | +172.45% | +158.74% | +142.85% | +142.85% | +154.71% | +146.92% | +145.15% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Asset turnover | 0.72 | 0.70 | 0.71 | 0.73 | 0.78 | 0.72 | 0.75 | 0.74 |
| Fixed-asset turnover | 8.30 | 9.45 | 9.66 | 10.03 | 10.75 | — | — | — |
| Inventory turnover | — | — | — | — | — | — | — | — |
| Receivables turnover | 4.86 | 5.27 | 6.13 | 6.97 | 7.47 | — | — | — |
| Payables turnover | 50.56 | 58.92 | 48.16 | 46.10 | 48.28 | — | — | — |
| Days outstanding | ||||||||
| Days sales outstanding (DSO) | 75.13 | 69.28 | 59.59 | 52.39 | 48.86 | — | — | — |
| Days inventory outstanding (DIO) | — | — | — | — | — | — | — | — |
| Days payables outstanding (DPO) | 7.22 | 6.20 | 7.58 | 7.92 | 7.56 | — | — | — |
| Cash conversion cycle | 67.91 | 63.08 | 52.01 | 44.47 | 41.30 | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 1.62 | 1.39 | 1.04 | 1.49 | 1.41 | 1.34 | 1.30 | 1.27 |
| FCF / Net income | 1.01 | 1.29 | 0.93 | 1.34 | 1.29 | 1.17 | 1.20 | 1.16 |
| FCF margin | +17.82% | +24.19% | +16.48% | +23.02% | +24.76% | +21.13% | +21.89% | +21.18% |
| OCF margin | +28.70% | +25.97% | +18.36% | +25.64% | +27.01% | +24.27% | +23.71% | +23.14% |
| CapEx / Revenue | +10.89% | +1.78% | +1.89% | +2.62% | +2.25% | +2.25% | +2.21% | +2.27% |
| CapEx / D&A | 1.08 | 0.20 | 0.21 | 0.29 | 0.26 | — | — | — |
| Stock-based comp / Revenue | +1.41% | +1.28% | +1.38% | +1.30% | +1.20% | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 4.12 | 4.94 | 5.02 | 5.23 | 6.24 | 6.85 | 7.25 | 7.90 |
| EPS · basic | 4.12 | 4.95 | 5.03 | 5.24 | 6.24 | 6.84 | 7.34 | 7.90 |
| Book value / share | 18.26 | 21.89 | 25.20 | 29.18 | 29.17 | 31.18 | 33.35 | 36.38 |
| Tangible BV / share | 2.49 | 2.07 | 5.01 | 8.77 | 8.77 | 31.18 | 33.35 | 36.38 |
| Sales / share | 23.24 | 26.44 | 28.42 | 30.34 | 32.52 | 34.98 | 36.52 | 39.07 |
| Operating CF / share | 6.67 | 6.87 | 5.22 | 7.78 | 8.78 | 8.49 | 8.66 | 9.04 |
| Free cash flow / share | 4.14 | 6.40 | 4.68 | 6.98 | 8.05 | 7.39 | 8.00 | 8.27 |
| Dividends / share | 1.84 | 1.89 | 2.01 | 2.13 | 2.25 | 2.40 | 2.59 | 2.72 |
| Payout ratio | +44.65% | +38.32% | +40.16% | +40.83% | +36.13% | +37.81% | +38.91% | +38.26% |
| Retention ratio | +55.35% | +61.68% | +59.84% | +59.17% | +63.87% | +62.19% | +61.09% | +61.74% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 7y CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Top-line | |||||||||
| Revenue · YoY | — | +10.50% | +6.94% | +6.63% | +7.21% | +6.49% | +5.90% | +6.65% | +7.18% |
| Gross profit · YoY | — | +17.19% | +5.45% | +6.69% | +10.75% | +6.08% | +4.60% | +7.81% | +8.29% |
| Profit | |||||||||
| Operating income · YoY | — | +19.04% | +1.28% | +1.81% | +16.21% | +2.91% | +4.89% | +8.38% | +7.59% |
| EBITDA · YoY | — | -6.38% | +4.31% | +4.99% | +12.17% | +6.81% | +4.74% | +4.47% | +4.32% |
| Net income · YoY | — | +16.52% | +1.03% | +4.14% | +19.36% | +0.56% | +6.49% | +6.71% | +7.62% |
| Operating | |||||||||
| EBIT · YoY | — | +19.04% | +3.16% | +5.06% | +15.95% | +0.10% | +9.98% | +6.01% | +8.29% |
| R&D · YoY | — | +11.29% | +17.57% | +3.91% | +9.79% | +4.76% | +6.12% | +5.61% | +8.34% |
| Per-share | |||||||||
| EPS · diluted · YoY | — | +19.90% | +1.62% | +4.18% | +19.31% | +9.76% | +5.92% | +8.95% | +9.75% |
| EPS · basic · YoY | — | +20.15% | +1.62% | +4.17% | +19.08% | +9.62% | +7.32% | +7.56% | +9.74% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Leverage | ||||||||
| Total debt | $115.13M | $275M | $150M | $0 | $0 | $61.28M | $63.92M | $67.89M |
| Net debt | $66.35M | $262.76M | $111.72M | -$101.95M | -$101.95M | -$27.58M | -$29.84M | -$34.34M |
| Net debt / EBITDA | 0.10 | 0.40 | 0.16 | -0.14 | -0.13 | -0.03 | -0.03 | -0.04 |
| Debt / equity | 0.08 | 0.17 | 0.08 | 0.00 | 0.00 | 0.03 | 0.03 | 0.03 |
| Debt / assets | +4.69% | +9.91% | +5.13% | 0.00% | 0.00% | +1.76% | +1.78% | +1.76% |
| Equity / assets | +56.26% | +57.99% | +63.00% | +70.00% | +70.00% | +64.64% | +68.07% | +68.89% |
| Coverage | ||||||||
| EBITDA / interest expense | 609.06 | 273.61 | 45.14 | 43.60 | 76.76 | 52.40 | 51.34 | 51.87 |
| Operating income / interest | 348.53 | 199.09 | 31.89 | 29.87 | 54.49 | 35.84 | 35.16 | 36.85 |
| Interest expense | $1.14M | $2.38M | $15.07M | $16.38M | $10.44M | $16.33M | $17.46M | $18.06M |
| Liquidity | ||||||||
| Current ratio | 1.13 | 1.20 | 1.00 | 1.27 | 1.27 | — | — | — |
| Quick ratio | 0.76 | 0.73 | 0.60 | 0.78 | 0.78 | — | — | — |
| Cash ratio | 0.09 | 0.02 | 0.06 | 0.19 | 0.19 | — | — | — |
| Working capital | $69.69M | $104.2M | -$1.8M | $145.68M | $145.68M | — | — | — |
| Working capital / revenue | +3.96% | +5.36% | -0.09% | +6.58% | +6.13% | — | — | — |
Sourced from key_metrics + financial_ratios (loaded by load_fundamentals_extended.py).
Valuation
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| P / E | — | — |
| P / B | — | — |
| EV / EBITDA | — | — |
| EV / Sales | 5.50x | 5.33x |
| Earnings yield | 3.5% | 3.2% |
| FCF yield | 4.5% | 4.3% |
Returns
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Gross margin | — | — |
| Operating margin | — | — |
| Net margin | — | — |
| ROE | 21.4% | 17.9% |
| ROA | 15.0% | 12.5% |
| ROIC | 17.6% | 15.0% |
Leverage & liquidity
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Debt / equity | — | — |
| Net debt / EBITDA | -0.13 | -0.14 |
| Interest coverage | — | — |
| Current ratio | 1.27x | 1.27x |
| Quick ratio | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).